Patents by Inventor Julian Priego SOLER

Julian Priego SOLER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240368193
    Abstract: The present invention provides compounds of the formula: wherein A, Z, G, R1, R2, and R4 are as described herein, pharmaceutically acceptable salts thereof, and methods of using these compounds and pharmaceutically acceptable salts thereof for treating patients for cancer.
    Type: Application
    Filed: March 29, 2024
    Publication date: November 7, 2024
    Inventors: Adedoyin David ABRAHAM, Alberto VALERO DE LA CRUZ, Alicia MARCOS LLORENTE, Alvaro ENRIQUEZ GARCIA, Andrew DILGER, Deqi GUO, Desta BUME, Frederic LAURENT CORDIER, Gaiying ZHAO, Isabel ROJO GARCIA, James Robert HENRY, Jason Eric LAMAR, Jolie Anne BASTIAN, Maria Lourdes PRIETO VALLEJO, Mario BARBERIS, Matthew Patrick BAUMGARTNER, Miguel GARZÓN SANZ, Pablo GARCIA LOSADA, Ramkumar RAJAMANI, Richard Duane JOHNSTON, Robert HAZLITT, Santiago CARBALLARES MARTIN, Sean ARONOW, Shane Michael WALLS, Sonia Maria GUTIERREZ SANFELICIANO, Steven ANDREWS, Timothy Scott KERCHER, Victoriano MOLERO FLÓREZ, Wenceslao LUMERAS AMADOR, William Rush SCAGGS, Juan Antonio RINCON CABEZUDO, Julián PRIEGO SOLER, Xiaohong CHEN
  • Publication number: 20240343736
    Abstract: The present invention provides compounds of the formula: wherein A, Z, G, R1, R2, and R4 are as described herein, pharmaceutically acceptable salts thereof, and methods of using these compounds and pharmaceutically acceptable salts thereof for treating patients for cancer.
    Type: Application
    Filed: March 29, 2024
    Publication date: October 17, 2024
    Inventors: Timothy Scott KERCHER, Desta BUME, Andrew DILGER, Adedoyin David ABRAHAM, Alberto VALERO DE LA CRUZ, Julián PRIEGO SOLER, Maria Lourdes PRIETO VALLEJO, Mario BARBERIS, Miguel GARZÓN SANZ, Ramkumar RAJAMANI, Sean ARONOW, Shane Michael WALLS, Sonia Maria GUTIERREZ SANFELICIANO, Victoriano MOLERO FLÓREZ, Xiaohong CHEN
  • Publication number: 20240343740
    Abstract: In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus.
    Type: Application
    Filed: May 19, 2022
    Publication date: October 17, 2024
    Inventors: Francisco Javier AGEJAS CHICHARRO, Renato Alejandro BAUER, Michael Gregory BELL, Qi CHEN, Graham Robert CUMMING, Todd FIELDS, Douglas Linn GERNERT, Joseph Daniel HO, Talbi Abelkader KAOUDI, Thierry Jean MASQUELIN, Jose Miguel MINGUEZ ORTEGA, Julian PRIEGO SOLER, Antonio RODRIGUEZ HERGUETA, Eric Michael WOERLY
  • Publication number: 20220169636
    Abstract: The present invention provides compounds of the Formula or a pharmaceutically acceptable salt thereof, and compounds processes for preparing the compounds and their salts, and a pharmaceutical composition.
    Type: Application
    Filed: February 15, 2022
    Publication date: June 2, 2022
    Inventors: Celia Lafuente BLANCO, Nuria Diaz BUEZO, Jose Antonio Martinez PEREZ, Gema Consuelo SANZ GIL, Julian Priego SOLER
  • Patent number: 11286249
    Abstract: The present invention provides compounds of the Formula wherein L is selected from the group consisting of —CH2NHCH2—, —CH2NH—, —NH—, —S—, —S(O)—, —S(O)2—, —O—, —OCH2—, —OCH2CH2O—, —NHSO2NH—, or a pharmaceutically acceptable salt thereof; a compound of the formula: processes for preparing the compounds and their salts, a pharmaceutical composition, and methods of treating patients in need of such treatment.
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: March 29, 2022
    Assignee: Eli Lilly and Company
    Inventors: Celia Lafuente Blanco, Nuria Diaz Buezo, Jose Antonio Martinez Perez, Gema Consuelo Sanz Gil, Julian Priego Soler
  • Publication number: 20210253559
    Abstract: The present invention provides compounds of the Formula wherein L is selected from the group consisting of —CH2NHCH2—, —CH2NH—, —NH—, —S—, —S(O)—, —S(O)2—, —O—, —OCH2—, —OCH2CH2O—, —NHSO2NH—, or a pharmaceutically acceptable salt thereof; a compound of the formula: processes for preparing the compounds and their salts, a pharmaceutical composition, and methods of treating patients in need of such treatment.
    Type: Application
    Filed: June 3, 2020
    Publication date: August 19, 2021
    Inventors: Celia Lafuente BLANCO, Nuria Diaz BUEZO, Jose Antonio Martinez PEREZ, Gema Consuelo SANZ GIL, Julian Priego SOLER